Literature DB >> 875054

Inhibition or enhancement of rat mammary tumors dependent on dose BCG.

W F Piessens, M Campbell, W H Churchill.   

Abstract

The effect of BCG on the growth of transplantable rat mammary tumors in W/Fu rats was studied. Admixture of mycobacteria to tumor cells in vitro prior to their injection in vivo either had no effect on or resulted in inhibition of or enhancement of the growth of the tumor transplants. Inhibition occurred at high and enhancement at low mycobacteria:tumor cell ratios. However, following suppression of local tumor growth with high doses of BCG, the growth of a second tumor graft was enhanced. Pretreatment of rats with BCG alone also enhanced the growth of a subsequent tumor graft. These results suggest an inverse relationship between the optimal dose of BCG for suppression of local tumor and that required to induced systemic immunity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 875054     DOI: 10.1093/jnci/59.1.207

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  4 in total

1.  Immunogenicity of viable tumor cells. A comparison of xenogenized tumor cells and BCG-tumor cell mixtures.

Authors:  Y Suzuki; K Suzuki; M Hosokawa; H Kobayashi
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

2.  Comparison of antitumor activity of Lactobacillus casei with other bacterial immunopotentiators.

Authors:  N Yasutake; M Ohwaki; T Yokokura; M Mutai
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

3.  Equine sarcoid: BCG immunotherapy compared to cryosurgery in a prospective randomised clinical trial.

Authors:  W R Klein; G E Bras; W Misdorp; P A Steerenberg; W H de Jong; R H Tiesjema; A W Kersjes; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

4.  Anti-tumour effect of humoral and cellular immunities mediated by a bacterial immunopotentiator, Lactobacillus casei, in mice.

Authors:  N Yasutake; M Ohwaki; M Mutai; Y Koide; T Yoshida
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.